Structural determinants of developmental toxicity in hamsters

Teratology

Volumn 60, Issue 4, 1999, Pages 190-205

  Gomez J ^a   Macina, O T ^a   Mattison, D R ^a   Zhang, Y P ^a   Klopman, G ^b   Rosenkranz, H S ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL TERATOGENESIS; DEVELOPMENTAL DISORDER; HAMSTER; MUTAGENICITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SALMONELLA; STRUCTURE ACTIVITY RELATION; TOXICITY;

ALGORITHMS; ANIMALS; CRICETINAE; MUTAGENICITY TESTS; MUTAGENS; RATS; SALMONELLA TYPHIMURIUM; STRUCTURE-ACTIVITY RELATIONSHIP; TERATOGENS; TOXICITY TESTS;

ANIMALIA; CRICETINAE; SALMONELLA;

EID: 0344172556     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199910)60:4<190::AID-TERA3>3.0.CO;2-U     Document Type: Article

References (81)

1. Ashby J. 1985. Fundamental structural alerts to potential carcinogenicity or non-carcinogenicity. Environ Mutagen 7:919-921.
2. Ashby J, Paton D. 1993. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 52 different chemical carcinogen exposures. Mutat Res 286:3-74.
3. Ashby J, Tennant RW. 1991. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP, Mutat Res 257:229-306.
4. Ashby J, Tennant RW. 1994. Prediction of rodent carcinogenicity for 44 chemicals: results. Mutagenesis 9:7-15.
5. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH. 1993. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262:2039-2042.
6. Bishop JB, Witt KL, Sloane RA. 1997. Genetic toxicities of human teratogens. Mutat Res 396:9-43.
7. Brent RL, Beckman DA. 1990. Environmental teratogens. Bull NY Acad Med 66:123-163.
8. Briggs GG, Freeman RK, Yaffe SJ. 1990. Drugs in pregnancy and lactation, 3rd ed. Baltimore: Williams & Wilkins. p 537.
9. Britz-Cunningham SH, Shah MM, Zuppan CW, Fletcher WH. 1995. Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N Engl J Med 332:1323-1329.
10. Bruzzone R, White TW, Goodenough DA. 1996. The cellular internet: on-line with connexins. Bioessays 18:709-718.
11. Chankong V, Haimes YY, Rosenkranz HS, Pet-Edwards J. 1985. The carcinogenicity prediction and battery selection (CPBS) method: a Bayesian approach. Mutat Res 153:135-166.
12. Cunningham AR, Klopman G, Rosenkranz HS. 1997. A dichotomy in the lipophilicity of natural estrogens/xenoestrogens and phytoestrogens. Environ Health Perspect [Suppl 3] 105:665-668.
13. Daston GP. 1996. The theoretical and empirical case for in vitro developmental toxicity screens, and potential applications. Teratology 53:339-344.
14. di Carlo FJ. 1990. Structure-activity relationships (SAR) affecting the teratogenicity of carboxylic acids. Drug Metab Rev 22:411-449.
15. Dunkel V, Zeiger E, Brusick D, McCoy EC, McGregor D, Mortelmans K, Rosenkranz HS, Simmon VF. 1984. Reproducibility of microbial mutagenicity assays: I. Tests with Salmonella typhimurium and Escherichia coli using a standard protocol. Environ Mutagen [Suppl 2]6:1-251.
16. Dunkel VC, Zeiger E, Brusick D, McCoy E, McGregor D, Mortelmans K, Rosenkranz HS, Simmon VF. 1985. Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli. Environ Mutagen [Suppl 5] 7:1-248.
17. Friedman JM, Polifka JE. 1994. Teratogenic effects of drugs: a resource for clinicians (TERIS). Baltimore: John Hopkins University Press. p 703.
18. Gabriel HD, Jung D, Butzler C, Temme A, Traub O, Winterhager E, Willecke K. 1998. Transplacental uptake of glucose is decreased in embryonic lethal connexin26-deficient mice. J Cell Biol 140:1453-1461.
19. Ghanooni M, Mattison DR, Zhang YP, Macina OT, Rosenkranz HS, Klopman G. 1997. Structural determinants associated with risk of human developmental toxicity. Am J Obstet Gynecol 176:799-806.
20. Gold LS, Sawyer CB, Magaw R, Backman GM, de Veciana M, Levinson R, Hooper NK, Havender WR, Bernstein L, Peto R, Pike MC, Ames BN. 1984. A carcinogenic potency database of the standardized results of animal bioassays. Environ Health Perspect 58:9-319.
21. Gold LS, de Veciana M, Backman GM, Magaw R, Lopipero P, Smith M, Blumenthal M, Levinson R, Bernstein L, Ames BN. 1986. Chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1982. Environ Health Perspect 67:161-200.
22. Gold LS, Slone TH, Backman GM, Magaw R, Da Costa M, Lopipero P, Blumenthal M, Ames BN. 1987. Second chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986. Environ Health Perspect 74:237-329.
23. Gold LS, Slone TH, Backman GM, Eisenberg S, Da Costa M, Wong M, Manley NB, Rohrbach L, Ames BN. 1990. Third chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987. Environ Health Perspect 84:215-286.
24. Gold LS, Manley NB, Slone TH, Garfinkel GB, Rohrbach L, Ames BN. 1993. The fifth plot of the carcinogenic potency database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989. Environ Health Perspect 100:65-135.
25. Guan X, Wilson S, Schlender KK, Ruch RJ. 1996. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18β-glycyrrhetinic acid. Mol Carcinog 16:157-164.
26. Henry B, Grant SG, Klopman G, Rosenkranz HS. 1998. Induction of forward mutations at the thymidine kinase locus of mouse lymphoma cells: evidence for electrophilic and non-electrophilic mechanisms. Mutat Res 397:313-335.
27. Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G, Mueller RF, Leigh IM. 1997. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 387:80-83.
28. Klopman G. 1984. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J Am Chem Soc 106:7315-7321.
29. Klopman G. 1992. MULTICASE 1. A hierarchical computer automated structure evaluation program. Quant Struct Act Rel 11:176-184.
30. Klopman G, Rosenkranz HS. 1991. Structure-activity relations: maximizing the usefulness of mutagenicity and carcinogenicity data bases. Environ Health Perspect 96:67-75.
31. Klopman G, Rosenkranz HS. 1994. Prediction of carcinogenicity/ mutagenicity using MULTICASE. Mutat Res 305:33-46.
32. Klopman G, Wang S. 1991. A computer automated structure evaluation (CASE) approach to calculation of partition coefficient. J Comput Chem 12:1025-1032.
33. Labbauf A, Klopman G, Rosenkranz HS. 1997. Dichotomous relationship between DNA reactivity and the induction of sister chromatid exchanges in vivo and in vitro. Mutat Res 377:37-52.
34. Liu M, Sussman N, Klopman G, Rosenkranz HS. 1996a. Estimation of the optimal data base size for structure-activity analyses: the Salmonella mutagenicity data base. Mutat Res 358:63-72.
35. Liu M, Sussman N, Klopman G, Rosenkranz HS. 1996b. Structure-activity and mechanistic relationships: the effects of chemical overlap on structural overlap in data bases of varying size and composition. Mutat Res 372:79-85.
36. Loch-Caruso R, Trosko JE. 1985. Inhibited intercellular communication as a mechanistic link between teratogenesis and carcinogenesis. Crit Rev Toxicol 16:157-183.
37. Macina OT, Zhang YP, Rosenkranz HS. 1998. Improved predictivity of chemical carcinogens: the use of a battery of SAR models. In: Kitchin KT, editor. Carcinogenicity: testing, predicting and interpreting chemical effects. New York: Marcel Dekker. p 227-250.
38. Matthews EJ, Spalding JW, Tennant RW. 1993. Transformation of BALB/C-3T3 cells. V. Transformation responses of 166 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassay. Environ Health Perspect [Suppl 2] 101:347-482.
39. Mortelmans K, Haworth S, Lawlor T, Speck WT, Tainer B, Zeiger E. 1986. Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ Mutagen 8:1-119.
40. Musil LS, Goodenough DA. 1990. Gap junctional intercellular communication and the regulation of connexin expression and function. Curr Opin Cell Biol 2:875-880.
41. Nendza M, Russom CL. 1991. QSAR modelling of the ERL-D fathead minnow acute toxicity database. Xenobiotica 21:147-170.
42. Rannug U, Sjogren M, Rannug A, Gillner M, Toftgard R, Gustafsson J-A, Rosenkranz H, Klopman G. 1991. Use of artificial intelligence in structure-affinity correlations of 2,3,7,8-tetrachlorodibenzo-P-dioxin (TCDD) receptor ligands. Carcinogenesis 12:2007-2016.
43. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J. 1995. Cardiac malformation in neonatal mice lacking connexin43. Science 267:1831-1834.
44. Rosenkranz HS, Klopman G. 1990a. The structural basis of the mutagenicity of chemicals in Salmonella typhimurium: the National Toxicology Program data base. Mutat Res 228:51-80.
45. Rosenkranz HS, Klopman G. 1990b. Evaluation of the ability of CASE, an artificial intelligence structure-activity relational system, to predict structural alerts for genotoxicity. Mutagenesis 5:525-527.
46. Rosenkranz HS, Klopman G. 1990c. Structural alerts to genotoxicity: the interaction of human and artificial intelligence. Mutagenesis 5:333-361.
47. Rosenkranz HS, Klopman G. 1990d. Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants. Mutat Res 228:105-124.
48. Rosenkranz HS, Klopman G. 1993a. Structural relationships between mutagenicity, maximum tolerated dose, and carcinogenicity in rodents. Environ Mol Mutagen 21:193-206.
49. Rosenkranz HS, Klopman G. 1993b. Structural evidence for a dichotomy in rodent carcinogenesis: involvement of genetic and cellular toxicity. Mutat Res 303:83-89.
50. Rosenkranz HS, Klopman G. 1993c. Predictions based upon the CASE structure-activity relational method are independent of the nature of the chemicals in the data base. Qual Assur Good Pract Regul Law 2:251-254.
51. Rosenkranz HS, Ennever FK, Dimayuga M, Klopman G. 1990. Significant differences in the structural basis of the induction of sister chromatid exchanges and chromosomal aberrations in Chinese hamster ovary cells. Environ Mol Mutagen 16:149-177.
52. Rosenkranz HS, Takihi N, Klopman G. 1991. Structure activity-based predictive toxicology: an efficient and economical method for generating non-congeneric data bases. Mutagenesis 6:391-394.
53. Rosenkranz HS, Zhang YP, Klopman G. 1994. Evidence that cell toxicity may contribute to the genotoxic response. Regul Toxicol Pharmacol 19:176-182.
54. Rosenkranz HS, Zhang YP, Klopman G. 1995. Risk identification using structural concepts: the potential carcinogenicity of praziquantel. Regul Toxicol Pharmacol 22:152-161.
55. Rosenkranz HS, Cunningham A, Klopman G. 1996. Identification of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens and antiestrogens. Mutagenesis 11:95-100.
56. Rosenkranz HS, Zhang YP, Macina OT, Mattison DR, Klopman G. 1998a. Human developmental toxicity and mutagenesis. Mutat Res 422:347-350.
57. Rosenkranz HS, Zhang YP, Klopman G. 1998b. The development and characterization of an SAR model of the Draize eye irritation test. ATLA26:779-809.
58. Rosenkranz HS, Cunningham AR, Zhang YP, Claycamp HG, Macina OT, Sussman NS, Grant SG, Klopman G. 1999. Development, characterization and application of SAR models. SAR and QSAR Environ Res (in press).
59. Rosenkranz M, Rosenkranz HS, Klopman G. 1997. Intercellular communication, tumor promotion and non-genotoxic carcinogenesis: relationships based upon structural considerations. Mutat Res 381:171-188.
60. Rosner B . 1995. Fundamentals of biostatistics, 4th ed. Belmont, CA: Wadsworth Publishing Co. p 682.
61. Sawey MJ, Goldschmidt MH, Risek B, Gilula NB, Lo CW. 1996. Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia. Mol Carcinog 17: 49-61.
62. Schardein JL. 1993. Chemically induced birth defects. New York: Marcel Dekker, Inc. p 902.
63. Shiels A, Mackay D, Ionides A, Berry V, Moore A, Bhattacharya S. 1998. A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q. Am J Hum Genet 62:526-532.
64. Simon AM, Goodenough DA, Li E, Paul DL. 1997. Female infertility in mice lacking connexin 37. Nature 385:525-529.
65. Swenberg JA, Short B, Borghoff S, Strasser J, Charbonneau M. 1989. The comparative pathobiology of α2μ-globulin nephropathy. Toxicol Appl Pharmacol 97:35-46.
66. Takihi N, Zhang YP, Klopman G, Rosenkranz HS. 1993a. Development of a method to assess the informational content of structure-activity data bases. Qual Assur Good Pract Regul Law 2:255-264.
67. Takihi N, Zhang YP, Klopman G, Rosenkranz HS. 1993b. An approach for evaluating and increasing the informational content of mutagenicity and clastogenicity data bases. Mutagenesis 8:257-264.
68. Takihi N, Rosenkranz HS, Klopman G, Mattison DR. 1994. Structural determinants of developmental toxicity. Risk Anal 14:649-657.
69. ter Haar E, Rosenkranz HS, Hamel E, Day BW. 1996. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. Bioorg Med Chem 4:1659-1671.
70. Trosko JE, Chang C-C. 1984. A possible mechanistic link between teratogenesis and carcinogenesis: inhibited intercellular communication. In: Chu EHY, Hollaender A, Generoso W, editors. Principles of environmental mutagenesis, carcinogenesis and teratogenesis. New York: Plenum Press, p 529-547.
71. Trosko JE, Chang C-C. 1986. Oncogene and chemical inhibition of gap-junctional intercellular communication: implications for teratogenesis and carcinogenesis. In: Ramel C, Lambert B, Magnusson J, editors. Genetic toxicology of environmental chemicals. Part B: genetic effects and applied mutagenesis. New York: Alan R. Liss. p 21-31.
72. Trosko JE, Chang C-C, Netzloff M. 1982. The role of inhibited cell-cell communication in teratogenesis. Teratogenesis Carcinog Mutagen 2:31-45.
73. Trosko JE, Madhukar BV, Chang C-C. 1993. Endogenous and exogenous modulation of gap junctional intercellular communication: toxicological and pharmacological implications. Life Sci 53:1-19.
74. Yang W-L, Klopman G, Rosenkranz HS. 1992. Structural basis of the in vivo induction of micronuclei. Mutat Res 272:111-124.
75. Zeiger E. 1987. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity. Cancer Res 47:1287-1296.
76. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K, Speck W. 1987. Salmonella mutagenicity tests: III. Results from 255 chemicals. Environ Mutagen [Suppl 9] 9:1-109.
77. Zeiger E, Anderson B, Haworth S, Lawlor T, Mortelmans K. 1988. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ Mol Mutagen [Suppl 12] 11:1-157.
78. Zeiger E, Ashby J, Bakale G, Enslein K, Klopman G, Rosenkranz HS. 1996. Prediction of Salmonella mutagenicity. Mutagenesis 11:471-484.
79. Zhang YP, van Praagh A, Klopman G, Rosenkranz HS. 1994. Structural basis of the induction of unscheduled DNA synthesis in rat hepatocytes. Mutagenesis 9:141-149.
80. Zhang YP, Sussman N, Macina OT, Rosenkranz HS, Klopman G. 1996. Prediction of the carcinogenicity of a second group of chemicals undergoing carcinogenicity testing. Environ Health Perspect [Suppl 5] 104:1045-1050.
81. Zhang YP, Sussman N, Klopman G, Rosenkranz HS. 1997. Development of methods to ascertain the predictivity and consistency of SAR models: application to the U.S. National Toxicology Program rodent carcinogenicity bioassays. Quant Struct Act Rel 16:290-295.